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ABSTRACT
Objectives The objective of this study was to describe 
variations in COVID-19 outcomes in relation to local risks 
within a well- defined but diverse single- city area.
Design Observational study of COVID-19 outcomes using 
quality- assured integrated data from a single UK hospital 
contextualised to its feeder population and associated 
factors (comorbidities, ethnicity, age, deprivation).
Setting/participants Single- city hospital with a feeder 
population of 228 632 adults in Wolverhampton.
Main outcome measures Hospital admissions (defined 
as COVID-19 admissions (CA) or non- COVID-19 admissions 
(NCA)) and mortality (defined as COVID-19 deaths or non- 
COVID-19 deaths).
Results Of the 5558 patients admitted, 686 died (556 
in hospital); 930 were CA, of which 270 were hospital 
COVID-19 deaths, 47 non- COVID-19 deaths and 36 
deaths after discharge; of the 4628 NCA, there were 
239 in- hospital deaths (2 COVID-19) and 94 deaths 
after discharge. Of the 223 074 adults not admitted, 407 
died. Age, gender, multimorbidity and black ethnicity 
(OR 2.1 (95% CI 1.5 to 3.2), p<0.001, compared with 
white ethnicity, absolute excess risk of <1/1000) were 
associated with CA and mortality. The South Asian cohort 
had lower CA and NCA, lower mortality compared with 
the white group (CA, 0.5 (0.3 to 0.8), p<0.01; NCA, 0.4 
(0.3 to 0.6), p<0.001) and community deaths (0.5 (0.3 
to 0.7), p<0.001). Despite many common risk factors for 
CA and NCA, ethnic groups had different admission rates 
and within- group differing association of risk factors. 
Deprivation impacted only the white ethnicity, in the oldest 
age bracket and in a lesser (not most) deprived quintile.
Conclusions Wolverhampton’s results, reflecting high 
ethnic diversity and deprivation, are similar to other 
studies of black ethnicity, age and comorbidity risk in 
COVID-19 but strikingly different in South Asians and 
for deprivation. Sequentially considering population and 
then hospital- based NCA and CA outcomes, we present 
a complete single health economy picture. Risk factors 
may differ within ethnic groups; our data may be more 
representative of communities with high Black, Asian 
and minority ethnic populations, highlighting the need for 
locally focused public health strategies. We emphasise the 
need for a more comprehensible and nuanced conveyance 
of risk.
INTRODUCTION
In understanding the natural history of 
disease, fundamental to healthcare, the 
COVID-19 pandemic highlights issues within 
data repositories. Constructing multiple- 
source data sets has complexity in case defi-
nition, data acquisition, integration, quality, 
Strengths and limitations of this study
 ► In contrast to the majority of other studies of fac-
tors related to COVID-19 morbidity and mortality, we 
used data from both a single- city hospital and its 
feeder population.
 ► Our observational study used a high- quality and 
complete data set from the local population and the 
hospital serving it to examine the association of pur-
ported risk factors with severity and mortality.
 ► Our study method enables assessment of the impor-
tance of evaluating such risks in the local, and not 
just national, population setting, taking into account 
the local variations in patient backgrounds.
 ► This nuanced approach factors in regional variation 
in elements such as ethnicity and deprivation by be-
ing specifically linked to the source population.
 ► Although limiting our study to the local population 
makes our findings less generalisable, it neverthe-
less allows evaluation of the importance of demo-
graphic and geographical variation.
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completeness, coding accuracy and the clinical meaning of 
analysis outcomes.1–4 Emphasising this challenge, national 
UK data were initially collated via the Patient Notification 
System, requiring a positive swab test up until 28 April 
2020 but revised to include clinical definitions given an 
estimated false- negative testing rate of up to 29%.5–8 Well- 
established primary care databases may have significant 
inaccuracy and do not include hospital secondary care 
information.9 A large UK primary care epidemiological 
study also used national COVID-19- positive (SARS- CoV-2) 
swab cases for case definition.2 Conversely, secondary care 
case series and international registry studies for specific 
diseases are not linked to primary care data sets.10–14 
Numerous studies have described the risk factors asso-
ciated with COVID-19 mortality, which have been from 
primary care, secondary care and meta- analyses.15 16 
Although these studies describe risk factors for severity, 
admission and mortality with COVID-19 infection, they 
typically use either large secondary care or primary care 
data sources, without amalgamating these data. There-
fore, important caveats exist in using and interpreting 
such data and drawing clinically important conclusions 
regarding the adverse associations of ethnicity with 
outcomes.2 17
Our objective, therefore, was to establish a tightly 
governed comprehensive, multisource, integrated, 
quality- assured local structured clinical data set, used for 
purposes of direct care; to define cohorts at risk; to system-
atically improve clinical coding and mortality- recording 
accuracy; to enable an informed understanding of factors 
influencing hospital activity, including admissions; and 
especially to describe variations in COVID-19 outcomes 
in relation to local risks within a well- defined but diverse 
single- city area. This approach should ultimately inform 
public health initiatives. We present a proof- of- principle 
study to evaluate the utility of this approach in relation to 
a single UK city- wide health district, reporting our find-
ings regarding population- wide factors that may have an 
association with two key COVID-19 outcomes, hospital 
admission and mortality, over the first 12 weeks of the 
pandemic in this city.
METHODS
General method
The time frame spanned from 1 March 2020 to 24 May 
2020.
Data were integrated into an SQL database from 
primary care, from community and hospital clinical 
and pathology systems for all people residing in Wolver-
hampton or registered to Wolverhampton practices, 
and from immediately adjacent districts with emergency 
admission to New Cross Hospital (NXH). Only those alive 
at the start point were included, and subsequently death 
and date of death were tracked. The final total popula-
tion aged >18 years was 228 632, of whom 1063 were resi-
dent but not Wolverhampton General Practitioner (GP) 
registered, 1521 were registered but not city resident and 
1026 were neither resident nor registered from imme-
diately surrounding areas with an emergency admission 
to NXH, such that 99.5% of the cohort were registered 
and/or resident constituting 88% of COVID-19 admis-
sions (CA) and 91% of COVID-19 deaths. The Index of 
Multiple Deprivation (IMD) was allocated according to 
postcode. Unavailable smoking status (15%) was reallo-
cated to ‘non- smoker’ (recognising that this is an assump-
tion which may potentially introduce slight bias). Missing 
body mass index (BMI) (22%) was replaced by age- related 
(5- year band) mean value in the cohort. Ethnicity data 
from all sources were reviewed, and only unambiguous 
data were accepted and recoded into Caucasian (white), 
South Asian, black, mixed ethnicity and Chinese, with 
7.5% remaining ‘unknown’. Comorbidities were accrued 
and cross- checked from primary care and hospital 
coding to include asthma, chronic obstructive pulmo-
nary disease (COPD), diabetes, hypertension, coronary 
artery disease, stroke and peripheral arterial disease, 
chronic heart failure, atrial fibrillation, chronic kidney 
disease (CKD), cancer, dementia, depression, other 
mental health disorders, epilepsy, learning difficulties, 
osteoarthritis, rheumatoid arthritis (RA), and recorded 
nursing home residency and palliative care status. Non- 
elective admissions over the preceding 12 months were 
ascertained. During admission, the COVID-19 clinical 
status was recorded by the Infection Diseases team or 
the clinical team in daily updates as ‘COVID-19 definite’, 
‘COVID-19 probable’ or ‘not COVID-19’. Formal end 
point coding was in duplicate, with a rolling triangulation 
audit in place comparing the clinical diagnosis, the coded 
diagnosis and the COVID-19 pathology status for coding 
accuracy. Mortality and cause of death were certified in 
our Medical Examiner System and also were continuously 
cross- checked against the coded status. COVID-19 coding 
and death certification arbitration were supported by the 
accountable senior responsible consultant (AV). Further 
validation against the National Strategic Tracing Service 
captured deaths outside hospital.
Statistical analysis
This analysis was undertaken in SPSS V.26. Factors anal-
ysis of all variables considered confounding effects and 
redundancy, yielding a nine- component rotated solution 
explaining 48% of the variance: deprivation and ethnicity 
were strongly coassociated in a single component, whereas 
the two principal outcome measures of hospital admis-
sion and mortality were in another distinct component. 
We adopted a multinomial regression analysis approach. 
This allowed the association of those independent factors 
with the dependent categorical variable, yielding ORs with 
their 95% CIs and statistical significance. The analysis was 
undertaken sequentially to ensure an a priori justification 
for further analysis. Statistical tests are described in the 
text and their results considered significant at p<0.05.
Patient and public involvement
None (not applicable to this type of study).
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Table 1 Demographic and clinical features and mortality outcomes of a whole adult population (n=228 632) categorised 
according to their hospital admission status during 12 weeks of the UK COVID-19 pandemic





Number (% of total) 228 632 223 074 (97.6) 4628 (2) 930 (0.4)
Age (years) 50.0±18.8 47.6±18.5 63.1±20.5 71.4±16.5 p<0.001
Gender (male, %) 114 866 (50.2) 50.3 48.4 55.2 p<0.001
Ethnicity (% in category)
  White 142 781 (62.5) 62.1 77.7 73.5 p<0.001
  South Asian 44 229 (19.3) 19.6 10.4 8.9
  Black 17 858 (7.8) 7.9 4.6 12.2
  Mixed 5809 (2.5) 2.6 1.3 0.6
  Chinese 806 (0.4) 0.4 0.1 0.2
  Unknown 17 149 (7.5) 7.5 5.8 4.5
Index of Multiple Deprivation 32.8±15.9 32.9±15.9 30.4±14.4 30.7±14.4 p<0.001
Smoking status (% never) 148 046 (64.8) 65 73 81 p<0.001
Body mass index (kg/m2) 27.3 (±5.7) 27.3 (±5.7) 27.8 (±5.1) 27.9 (±4.6) p<0.001




6% (0.4%) 31% (7%) 35% (8%) p<0.001
Any comorbidity (≥3) 110 564 (48%)
(12%)
48% (11%) 77% (41%) 88% (58%) p<0.001
Palliative care registered (%) 1530 (0.7) 0.5 4.9 13.9 p<0.001
Nursing home resident (%) 2130 (0.9) 0.8 4.7 9.7 p<0.001
Hypertension (%) 47 830 (20.9) 20.2 47.6 64.2 p<0.001
Depression (%) 39 153 (17) 17.0 22.4 18.7 p<0.001
Asthma (%) 30 335 (13.3) 13.2 16.1 16.3 p<0.001
Diabetes (%) 20 529 (9.0) 8.6 21.4 33.8 p<0.001
Ischaemic heart disease (%) 10 965 (4.8) 4.4 19.9 23.2 p<0.001
Chronic kidney disease (%) 10 265 (4.5) 4.1 17.6 29.0 p<0.001
Cancer (%) 9796 (4.3) 4.0 16.0 17.8 p<0.001
Atrial fibrillation (%) 6771 (3.0) 2.6 4.7 8.7 p<0.001
Chronic obstructive pulmonary 
disease (%)
6762 (3.0) 2.7 12.3 15.1 p<0.001
Cerebrovascular disease (%) 5359 (2.3) 2.2 8.8 13.5 p<0.001
Cardiac failure (%) 4940 (2.2) 1.9 13.1 20.8 p<0.001
Osteoarthritis (%) 4267 (1.9) 1.7 8.0 11.2 p<0.001
Epilepsy (%) 4035 (1.8) 1.7 3.8 4.5 p<0.001
Rheumatoid arthritis (%) 3284 (1.4) 1.4 4.2 6.2 p<0.001
Mental health disorder (%) 2967 (1.3) 1.3 1.7 1.7 p<0.05
Peripheral vascular disease (%) 2724 (1.2) 1.1 4.7 8.7 p<0.001
Dementia (%) 2304 (1.0) 0.9 4.0 7.8 p<0.001
Learning difficulties (%) 1597 (0.7) 0.7 1.0 1.2 p<0.05
Vital status (n, % died) 1093 (0.5) 407, 0.2 333, 7.2* 353, 38† p<0.001
Data are presented as mean±SD or as percentages. Between- groups analysis is by analysis of variance or by χ2 for scale or categorical 
variables, respectively. Comorbidities are listed in descending order of frequency.
*237 non- COVID-19 hospital deaths, 94 postdischarge deaths in community and 2 hospital COVID-19 deaths.
†270 hospital COVID-19 deaths, 47 non- COVID-19 hospital deaths and 36 postdischarge deaths in community.
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The population characteristics are shown in table 1, 
grouped according to admission status (no admission 
(NA), non- COVID-19 admission (NCA) and CA) together 
with their mortality rates.
Compared with NA, there was an increased associa-
tion of all variables with NCA and CA, including age, the 
number of comorbidities, most individual comorbidities, 
surrogate measures of dependency (of being on a pallia-
tive care register or being a nursing home resident) and 
history of emergency admissions. Male gender, BMI, IMD 
and smoking status were significantly different between 
the three categories. Ethnic minority groupings were 
significantly different between admission types, with the 
South Asian population prevalence in CA being 46% of 
that in the comparator NA population, whereas the black 
population appeared to have a 56% excess. Table 2 gives 
further numerical details.
The three hospital admission categories (NA, NCA, 
CA) were taken as the response variable and submitted 
to multinomial regression (table 3). The complete model 
was highly significant (χ2=8869.1, p<0.001). Male gender 
was more prevalent in CA.
The age distribution (figure 1A) differed significantly 
for CA and NCA versus NA, and the two admission 
groups differed significantly from each other, reflecting 
the higher mean age in CA. The pattern for deprivation 
(figure 1B) showed the peak admission rates to be in the 
second least deprived quintile, with the most deprived 
quintile not being significantly different from the least 
deprived quintile, whereas the two admission groups did 
not differ significantly from each other in this regard. 
There was a decreased relative risk for admission in either 
group with current or previous smoking. Both admission 
groupings had a significantly increased history of prior 
emergency admissions, established multimorbidity, being 
a nursing home resident or being in a palliative phase of 
care, with these latter two characteristics in significantly 
higher prevalence in CA compared with NCA. Both 
groups shared individual comorbidities in higher risk, 
but with some differential effect for diabetes, hyperten-
sion, atrial fibrillation and peripheral vascular disease 
which were increased in CA.
The South Asian ethnic group was less likely to have 
a CA or NCA (60% and 50% crude percentage reduced 
risk, respectively) compared with the white ethnic refer-
ence category, whereas the black ethnic group shared 
the significant propensity not to have an NCA but had a 
markedly increased relative risk (70%) for CA. Ethnicity- 
related outcomes were examined specifically among those 
with CA, by comparing those admitted with those not 
admitted within their ethnic category in separate binary 
regression analyses (all χ2>252.4, p<0.001) (table 4).
Age, gender, prior emergency admissions, palliative 
phase, comorbidity and nursing home residence were 
significant associations in two or more of the ethnic groups. 
Of note, patterns of significantly associated individual 
comorbidities were different between the ethnic groups: 
black—hypertension, atrial fibrillation and cardiac failure; 
South Asian—diabetes, peripheral vascular disease and 
atrial fibrillation; white—specific association with COPD, 
CKD and RA. Deprivation had a significant impact only 
in the white group. The inter- relationship of age, depriva-
tion with ethnicity and the impact of white ethnicity in the 
oldest quintile in lesser deprived categories can be seen 
Table 2 COVID-19 admission and death by ethnic category showing numbers, absolute rates per 1000 population, and 
excess risk and ORs (95% CI) versus the white group as comparator
White South Asian Black Other or unknown
Total numbers 142 781 (63%) 44 229 (19%) 17 858 (8%) 23 764 (10%)
COVID-19 admission 684 (74%) 83 (9%) 113 (12%) 50 (5%)
COVID-19 admission/1000 4.8 1.9 6.3 2.1
COVID-19 admission excess risk/1000 Comparator −2.9 1.5 −2.7
COVID-19 admission OR Comparator 0.39 (0.31 to 0.48), 
p<0.001
1.31 (1.07 to 1.59), 
p<0.001
0.43 (0.33 to 0.58), 
p<0.001
COVID-19 death 190 (70%) 32 (12%) 39 (14%) 11 (4%)
COVID-19 death/1000 1.3 0.7 2.2 0.5
COVID-19 death excess risk/1000 Comparator −0.6 0.9 −0.9
COVID-19 death OR Comparator 0.54 (0.37 to 0.79), 
p<0.01
1.64 (1.16 to 2.31), 
p<0.01




0.3 0.4 0.3 0.2
COVID-19 death in COVID-19 admission 
OR
Comparator 1.55 (0.96 to 2.51), 
p=0.075, ns
1.19 (0.78 to 1.83), 
p=0.423, ns
0.63 (0.32 to 1.25), 
p=0.187, ns
‘Chinese’, ‘mixed’ and ‘unknown’ categories showed no significant associations as individual categories in this analysis or when merged as 
‘other or unknown’.
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in figure 1C. In a simplified model of admission type and 
ethnicity (χ2=4542.9, p<0.001) with only age and depriva-
tion entered categorically together with their interaction 
(χ2=412.7, p<0.001), the ORs for CA compared with the 
white group were as follows: black, 2.08 (1.70 to 2.57) 
(p<0.001) and South Asian, 0.56 (0.44 to 0.70) (p<0.001), 
with both groups still less likely to have NCA (p<0.001).
Absolute risk of CA within ethnic groups
The absolute risk from COVID-19 hospital admission 
was 4.8/1000 population, and table 2 shows this broken 
down by ethnic grouping giving numbers, percentages, 
absolute risk and excess risk with ORs compared with the 
white group, with the South Asian group showing a lower 
and the black group a higher absolute risk as reflected in 
ORs.
Mortality outcomes
COVID-19 hospital deaths, non- COVID-19 hospital 
deaths and deaths in the community (CHD, NCHD, DIC) 
were analysed in stepwise backward multinomial regres-
sion (χ2=5548.3, p<0.001) (table 5).
Table 3 Multinomial regression for the association of factors with COVID-19- related or non- COVID-19- related emergency 
hospital admissions (HA) compared with the reference category of those not admitted (n=223 074)
CHA NCHA CHA vs NCHA
Number (% of population) 930 (0.4%) 4628 (2%)   
Gender (male) 1.5 (1.3 to 1.7), p<0.001 ns, p=0.48 1.3 (1.1 to 1.5), p<0.001
Age category Q2 (30–40) 2.7 (1.5 to 5), p<0.01 1.2 (1 to 1.3), p<0.05 2.2 (1.2 to 4), p<0.05
Age category Q3 (41–51) 5.1 (2.9 to 9), p<0.001 1.4 (1.2 to 1.6), p<0.001 3.2 (1.8 to 5.8), p<0.001
Age category Q4 (52–65) 7.8 (4.6 to 13.4), p<0.001 1.7 (1.5 to 1.9), p<0.001 3.7 (2.1 to 6.5), p<0.001
Age category Q5 (66–113) 16.6 (9.7 to 28.3), p<0.001 2.9 (2.5 to 3.3), p<0.001 4.7 (2.7 to 8.1), p<0.001
IMD category Q2 (16.5–27.7) 1.8 (1.4 to 2.2), p<0.001 2 (1.8 to 2.2), p<0.001 ns
IMD category Q3 (27.8–39.0) 1.7 (1.4 to 2.1), p<0.001 1.5 (1.4 to 1.7), p<0.001 ns
IMD category Q4 (39.3–45.7) 1.6 (1.3 to 2), p<0.001 1.4 (1.3 to 1.6), p<0.001 ns
IMD category Q5 (45.7–71.8) ns, p=0.517 ns, p=0.574 ns
Ethnicity South Asian 0.4 (0.3 to 0.5), p<0.001 0.5 (0.4 to 0.5), p<0.001 1 (0.7 to 1.2), ns, 0.735
Ethnicity black 1.7 (1.3 to 2.1), p<0.001 0.6 (0.5 to 0.7), p<0.001 3.1 (2.4 to 4), p<0.001
Smoking current or prior 0.3 (0.2 to 0.3), p<0.001 0.5 (0.4 to 0.5), p<0.001 0.7 (0.5 to 0.8), p<0.001
Prior emergency admissions (1 year) 1.6 (1.5 to 1.7), p<0.001 1.8 (1.7 to 1.8), p<0.001 0.9 (0.9 to 1), p<0.05
Palliative care registered 4.1 (3.2 to 5.1), p<0.001 1.7 (1.4 to 2), p<0.001 2.4 (1.9 to 3.1), p<0.001
Nursing home resident 1.7 (1.3 to 2.3), p<0.001 1.2 (1 to 1.5), ns, 0.058 1.7 (1.3 to 2.2), p<0.001
Comorbidities ≥3 1.5 (1.2 to 1.9), p<0.01 1.4 (1.3 to 1.6), p<0.001 ns
Chronic obstructive pulmonary disease 1.9 (1.5 to 2.3), p<0.001 1.8 (1.6 to 2), p<0.001 ns
Peripheral vascular disease 1.8 (1.4 to 2.3), p<0.001 1.2 (1 to 1.4), p<0.05 1.5 (1.1 to 2), p<0.01
Atrial fibrillation 1.7 (1.4 to 2.1), p<0.001 1.4 (1.2 to 1.5), p<0.001 1.3 (1.1 to 1.6), p<0.01
Diabetes 1.6 (1.4 to 1.9), p<0.001 1.3 (1.2 to 1.4), p<0.001 1.4 (1.2 to 1.6), p<0.001
Cardiac failure 1.6 (1.3 to 1.9), p<0.001 1.4 (1.2 to 1.6), p<0.001 ns
Rheumatoid arthritis 1.5 (1.1 to 2), p<0.01 ns, p=0.134 ns
Epilepsy 1.4 (1 to 2), p<0.05 1.4 (1.2 to 1.6), p<0.001 ns
Chronic kidney disease 1.3 (1.1 to 1.6), p<0.01 1.2 (1 to 1.3), p<0.01 ns
Hypertension 1.2 (1 to 1.5), p<0.05 ns, p=0.196 1.2 (1 to 1.4), p<0.05
Cancer 1.2 (1 to 1.5), p<0.05 1.6 (1.5 to 1.8), p<0.001 0.8 (0.7 to 1), p<0.05
Cerebrovascular disease ns, p=0.101 1.2 (1 to 1.3), p<0.05 ns
Ischaemic heart disease ns, p=0.859 1.5 (1.3 to 1.6), p<0.001 0.7 (0.6 to 0.9), p<0.01
Depression ns, p=0.34 1.1 (1 to 1.2), p<0.01 ns
Dementia ns, p=0.059 0.8 (0.7 to 1), p<0.05 ns
Data are OR with 95% CIs. For age and IMD as categorical ordinal variables (data ranges shown), the comparators were the youngest and 
least deprived quintiles, respectively. Comorbidity associations are listed in descending OR order for the CA group. The comparison of CA vs 
NCA was by binary logistic regression. Variables not listed (table 1) were excluded stepwise as not significant.
CA, COVID-19 admissions; CHA, COVID-19 hospital admissions; IMD, Index of Multiple Deprivation; NCA, non- COVID-19 admissions; NCHA, 
non- COVID-19 hospital admissions.
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Male gender was significantly positively associated with 
mortality in all three categories. Increasing age was a signif-
icant factor, but there was no significant difference in age 
quintile distribution (χ2=12.168, p=0.144, ns) with 89%, 
84% and 86% in the oldest quintile in the CHD, NCHD 
and DIC groups, respectively. For deprivation, for CHD 
and NCHD, the pattern mirrored that of hospital admis-
sion with significantly increased mortality rates in the 
lesser deprived quintiles but not in the highest quintile, 
whereas for DIC, a significant effect showing an increased 
mortality rate was only seen in the most deprived quintile. 
All categories shared a propensity for greater prior emer-
gency admissions, multimorbidity and being in a pallia-
tive phase of care, while being a nursing home resident 
was associated with death in the community rather than 
HD. Individual morbidities varied in their associations, 
noting that diabetes and CKD were in increased associ-
ation with mortality only in the CHD group. The black 
ethnic minority had significantly higher and the South 
Asian group had significantly lower COVID-19 hospital 
mortality rate, proportionately mirroring admission 
rates. Directly comparing CHD with NCHD confirmed 
a significantly increased association with black ethnicity 
(OR 4.6 (2 to 10.2), p<0.003), diabetes (OR 1.5 (1 to 2.3), 
p<0.005) and CKD (OR 1.6 (1.1 to 2.3), p<0.004) and an 
even greater negative association with current or previous 
smoking (OR 0.1 (0 to 0.3), p<0.002).
Absolute risk of COVID-19 death by ethnic group
Specifically for COVID-19 death, table 2 shows numbers, 
percentages, absolute risk and excess risk with unadjusted 
ORs for the ethnic minorities compared with the white 
group, and figure 2A shows the distribution of mortality 
outcome by ethnic category (χ2=126.1, p<0.001). The 
absolute risk of COVID-19 death was 1.32, 0.73 and 2.2 
per 1000 population in the white, South Asian and black 
ethnic groups, and the excess risk was −0.61 (negative) 
and 0.85 deaths per 1000 population in the South Asian 
and black versus white group, respectively. Compared 
with the white population, the unadjusted OR (95% CI) 
for COVID-19 death for the black and Asian groups was 
1.6 (1.2 to 2.3) and 0.5 (0.4 to 0.8), respectively (both 
p<0.01). The ethnic groups differed significantly in age 
(white, 50±20; South Asian, 45±16; black, 45±17 years; 
F=1868.9, p<0.001), and age was the dominant factor 
associated with hospital admission and death (tables 1 
and 3–5). To avoid any potential misrepresentation of 
mortality outcomes by statistical age adjustment, the 
absolute effects were considered for the oldest quintile 
only where 84% of all COVID-19 deaths occurred, in 
which case the ORs were as follows: black, 3.9 (2.7 to 5.6) 
(p<0.001) and South Asian, 0.9 (0.6 to 1.4) (p=0.72, ns) 
(figure 2B).
COVID-19 hospital admission and COVID-19 mortality
By introducing hospital admission status, the COVID-19 
mortality ORs—black, 1.3 (0.9 to 2.0) (p=0.206, ns) and 
South Asian, 1.5 (0.9 to 2.3) (p=0.098, ns)—were similar, 
indicating similar in- hospital mortality in contrast to the 
whole population effect. To negate this potential effect 
of prior propensity for acquisition of serious COVID-19 
infection, and focusing on the black and South Asian 
minorities compared with the white majority, a narrower 
assessment of those who were admitted with COVID-19 
and had a COVID-19 death was made. Among 930 CA, 
excluding those with a CA but with non- COVID-19 death 
(n=83 (9%)), COVID-19 death occurred in 270 patients 
(32%) (white, 189; South Asian, 32; black, 38; other, 11). 
The ORs for the association of ethnicity with COVID-19 
mortality were as follows: black, 1.2 (0.7 to 1.8) (p=0.423, 
ns) and South Asian, 1.6 (1.0 to 2.5) (p=0.075, ns) 
(χ2=5.92, p=0.115, ns) (figure 2C). Using the full model 
with all independent variables, including age, which 
remained significantly different between ethnic groups 
(F=13.23, p<0.001), the significantly associated variables 
were age, gender, smoking status, BMI, palliative phase of 
life, multimorbidity and the individual comorbidities of 
Figure 1 Age and deprivation in relation to hospital 
admission and in whole population. The association of age 
(A) and deprivation (B) with hospital admission type. (C) Inter- 
relationship of age, deprivation and ethnicity in the whole 
population (n=228 632) (other/unknown ethnic groups not 
shown).
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cardiac failure, CKD and peripheral vascular disease but 
not ethnic grouping or deprivation score (table 6).
Finally, table 2 shows the absolute risks of COVID-19 
death in COVID-19 hospital admission and ORs, which 
are consistent with the findings of the modelled data.
DISCUSSION
Principal findings
Over and above known general associations with hospital 
admission and mortality, our study suggests a complex 
association of deprivation and points to heterogeneity of 
the impact of ethnicity, both of which may vary by locality. 
We highlight the need for local health economies to have 
robust, accurate and integrated clinical data to assess 
and inform local decision- making, and, in particular, at 
a time of heightened anxiety, we raise a concern about 
the conveyance of risk to local communities. The crucial 
differences in relationship to other studies are as follows:
General associations
Uncontroversially, factors associated with NCA or 
COVID-19 hospital admission and death included age, 
gender, prior emergency admissions, palliative phase of 
life, nursing home residence and multimorbidity with 
specific comorbidities associated with CA or death and 
with ethnic status. Within the limitations of our study, 
we have found smokers as an under- represented group 
in CA and mortality. Although a number of hypotheses 
have been proposed to account for a possible protective 
effect, this remains an area under further evaluation.18 It 
is suggested that any association of smoking with better 
COVID-19 outcomes, observed in some other studies,2 19 
may be questioned when taken in the context of this being 
common to NCA and death during this period.
CA versus NCA
The significant differences were age, gender and degree of 
comorbidity complexity (palliative care, nursing home), 
Table 4 Outcomes by individual ethnic category for those specifically with COVID-19 hospital admissions compared those 
not admitted within individual ethnic grouping as examined in binary regression analysis
Black South Asian White
Numbers admitted/not admitted 113 (0.6%)/17 530 83 (0.2%)/43 663 684 (0.5%)/138 500
Gender (male) ns 2 (1.2 to 3.2), p<0.01 1.6 (1.4 to 1.9), p<0.001
Age category Q2 (30–40) 2.3 (0.6 to 8.6), ns, 
p=0.225
1.8 (0.5 to 6.8), ns, p=0.417 3 (1.3 to 6.8), p<0.01
Age category Q3 (41–51) 3.1 (0.9 to 11), ns, p=0.083 2.6 (0.7 to 9.3), ns, p=0.148 4.9 (2.2 to 10.5), p<0.001
Age category Q4 (52–65) 3.8 (1.1 to 13.4), p<0.05 3.1 (0.9 to 10.8), ns, 
p=0.082
9.7 (4.7 to 20), p<0.001
Age category Q5 (66–113) 10 (2.8 to 36), p<0.001 4.5 (1.3 to 16), p<0.05 21.2 (10.4 to 43.3), 
p<0.001
IMD category Q2 (16.5–27.7) ns ns 1.7 (1.4 to 2.1), p<0.001
IMD category Q3 (27.8–39.0) ns ns 1.6 (1.3 to 2.1), p<0.001
IMD category Q4 (39.3–45.7) ns ns 1.5 (1.2 to 2), p<0.01
IMD category Q5 (45.7–71.8) ns ns ns
Smoking current or prior 0.3 (0.2 to 0.6), p<0.001 0.2 (0.1 to 0.6), p<0.01 0.3 (0.2 to 0.3), p<0.001
Prior emergency admissions (1 year) ns 1.5 (1.2 to 1.8), p<0.001 1.5 (1.4 to 1.6), p<0.001
Palliative care registered 3.8 (1.8 to 8), p<0.001 11 (5.5 to 21.7), p<0.001 3.8 (2.9 to 5), p<0.001
Nursing home resident ns 4.5 (1.4 to 14.2), p<0.05 1.6 (1.1 to 2.2), p<0.01
Comorbidities ≥3 2.6 (1.5 to 4.4), p<0.001 ns 1.7 (1.3 to 2.1), p<0.001
Atrial fibrillation 2 (1 to 3.7), p<0.05 2.8 (1.4 to 5.6), p<0.01 1.6 (1.3 to 2), p<0.001
Cardiac failure 2.2 (1.2 to 3.9), p<0.05 ns 1.7 (1.3 to 2.1), p<0.001
Chronic kidney disease ns ns 1.4 (1.1 to 1.7), p<0.01
Chronic obstructive pulmonary disease ns ns 1.9 (1.5 to 2.3), p<0.001
Diabetes ns 4.4 (2.6 to 7.5), p<0.001 1.5 (1.3 to 1.9), p<0.001
Hypertension 2.2 (1.2 to 4.1), p<0.01 ns ns
Peripheral vascular disease ns 3.7 (1.6 to 8.8), p<0.01 1.9 (1.4 to 2.5), p<0.001
Rheumatoid arthritis ns ns 1.6 (1.1 to 2.1), p<0.01
Values are OR with 95% CIs.
IMD, Index of Multiple Deprivation.
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but as it is likely that patterns of emergency admissions 
differed at this time, comparisons of COVID-19 with non- 
COVID-19 hospital admission may have little relevance 
to COVID-19 outcomes, noteworthy for studies that have 
reported on COVID-19 hospital admission alone.12 13 20
Deprivation
For hospital NCA and CA and death, the pattern was for 
excess in lesser deprived quintiles in the white ethnic 
population but not within ethnic minority groups where 
deprivation was not a significant factor. This contrasts with 
other studies2 5: in some, deprivation was not a significantly 
associated factor in fully adjusted models,21 whereas other 
UK studies,20 and most overseas studies, have not consid-
ered this.12 13 Following the H1N1 pandemic influenza 
of 2009, many studies indicated effects of deprivation, 
including a rural–urban divide impact,22 as is seen in this 
pandemic.15 Our findings within a health economy (ie, 
based on a local population) with significant deprivation 
call for the need to explore this association within larger 
studies, specifically within urban areas.
Ethnicity
We note that a recent meta- analysis shows heterogeneity 
in the association of ethnicity with COVID-19 mortality.23 
In a large population study reporting adverse ORs for 
all ethnic groups, their crude unadjusted data showed 
significantly increased risk in the black (χ2=17.464, 
p<0.001) but not in the South Asian group (χ2=3.238, 
p=0.072).2 This was also shown in another population- 
level study.15 In the largest reported hospital admission 
series, both ethnic groups had significantly lower unad-
justed mortality rates,17 whereas in their modelled data 
no effect was seen among the black population. In a study 
Table 5 Multinomial regression of mortality outcomes over the 12- week period for those who died (n=1093) either in the 
community (n=537) or non- COVID-19- related (n=284) and COVID-19- related (n=272) hospital deaths (HD) (see table 1) 
compared with those who were alive (n=227 539)
COVID-19 HD Non- COVID-19 HD Community death
Gender (male) 2 (1.5 to 2.6), p<0.001 1.5 (1.2 to 1.9), p<0.01 1.7 (1.4 to 2.1), p<0.001
Age category Q2 (30–40) ns, p=0.997 >100, p<0.001 ns, p=0.85
Age category Q3 (41–51) 2.5 (0.5 to 14), ns, p=0.283 >100, p<0.001 6.6 (1.9 to 22.6), p<0.01
Age category Q4 (52–65) 10.5 (2.4 to 44.8), p<0.01 >100, p<0.001 13.9 (4.3 to 44.9), p<0.001
Age category Q5 (66–113) 39.9 (9.6 to 165.5), p<0.001 >100, p<0.001 41.3 (13 to 130.9), p<0.001
IMD category Q2 (16.5–27.7) ns, p=0.163 1.8 (1.2 to 2.6), p<0.01 ns, p=0.708
IMD category Q3 (27.8–39.0) 1.5 (1 to 2.2), p<0.05 2.2 (1.5 to 3.1), p<0.001 ns, p=0.054
IMD category Q4 (39.3–45.7) ns, p=0.319 1.8 (1.2 to 2.7), p<0.01 ns, p=0.384
IMD category Q5 (45.7–71.8) ns, p=0.713 ns, p=0.455 1.6 (1.2 to 2.1), p<0.01
Ethnicity South Asian 0.5 (0.3 to 0.8), p<0.01 0.4 (0.3 to 0.6), p<0.001 0.5 (0.3 to 0.7), p<0.001
Ethnicity black 2.1 (1.5 to 3.2), p<0.001 0.5 (0.3 to 1), p<0.05 ns, p=0.841
Smoking current or prior 0 (0 to 0), p<0.001 0.1 (0.1 to 0.2), p<0.001 0.1 (0.1 to 0.1), p<0.001
Body mass index 1 (0.9 to 1), p<0.01 1 (1 to 1), ns, p=0.12 1 (1 to 1), p<0.05
Prior emergency admissions (1 year) 1.2 (1.1 to 1.3), p<0.001 1.3 (1.2 to 1.4), p<0.001 1.3 (1.2 to 1.4), p<0.001
Palliative care registered 9.5 (6.8 to 13.2), p<0.001 5.9 (4.2 to 8.4), p<0.001 5.9 (4.7 to 7.5), p<0.001
Nursing home resident ns, p=0.547 ns, p=0.634 3.5 (2.7 to 4.6), p<0.001
Comorbidities ≥3 3 (2 to 4.4), p<0.001 2.3 (1.6 to 3.3), p<0.001 1.7 (1.3 to 2.3), p<0.001
Peripheral vascular disease 2.6 (1.8 to 3.9), p<0.001 1.9 (1.3 to 2.9), p<0.01 ns, p=0.232
Chronic obstructive pulmonary disease 2.1 (1.4 to 3), p<0.001 3.8 (2.8 to 5.2), p<0.001 2.2 (1.7 to 2.9), p<0.001
Cardiac failure 2 (1.5 to 2.8), p<0.001 1.7 (1.2 to 2.3), p<0.01 1.8 (1.4 to 2.3), p<0.001
Chronic kidney disease 1.6 (1.2 to 2.1), p<0.01 ns, p=0.095 ns, p=0.328
Diabetes 1.4 (1.1 to 1.9), p<0.05 ns, p=0.465 ns, p=0.426
Atrial fibrillation 1.4 (1 to 1.9), p<0.05 1.9 (1.4 to 2.6), p<0.001 ns, p=0.602
Cancer ns, p=0.338 1.5 (1.1 to 2), p<0.01 2.1 (1.7 to 2.6), p<0.001
Dementia ns, p=0.878 ns, p=0.505 2 (1.5 to 2.6), p<0.001
Asthma ns, p=0.337 0.7 (0.5 to 1), p<0.05 ns, p=0.376
Results are OR with 95% CIs. For age and Index of Multiple Deprivation categories, the comparators were the youngest and least deprived 
quintile, respectively. Variables not listed from table 1 were excluded stepwise (backwards) as not significant.
IMD, Index of Multiple Deprivation.
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from New York, there was no adverse ethnicity signal,12 13 
and early reported adverse ethnicity outcomes in the 2009 
UK influenza pandemic24 did not withstand subsequent 
review.25 We find that our black population had signifi-
cantly higher and the South Asian population lower crude 
and adjusted CA rates compared with the white popula-
tion, also observing that both ethnic subgroups had lower 
non- COVID-19 hospital admissions, further contextual-
ising the strong effect in the black cohort. In both groups, 
their crude and adjusted patterns of COVID-19 mortality 
mirrored that of COVID-19 hospital admission, but from 
the numerical base of CA, there was no significant differ-
ence between the black and South Asian groups compared 
with the white group, highlighting pitfalls of examining 
effects in isolation. Our data in the black population are 
broadly in keeping with some studies showing excess 
COVID-19 hospitalisation and mortality, but the South 
Asian group’s lower absolute and adjusted rate of admis-
sion and death from COVID-19 are strikingly different. 
Given the variation in findings to date, we do not consider 
this an ‘unexpected finding’ and hypothesise that many 
local population factors are at play, including population 
density, family size, housing, duration of immigration, 
country of birth (including UK born) and occupation, 
and the precise ethnic group within the ‘South Asian’ 
population may well be of importance. A recent updated 
analysis by the UK Office for National Statistics has 
emphasised that ‘ethnic differences in mortality involving 
COVID-19 are most strongly associated with demographic 
and socio- economic factors, such as place of residence 
and occupational exposures, and cannot be explained 
by pre- existing health conditions’, which conclusion is 
consistent with our locally dictated findings.26 Otherwise 
within Black, Asian and minority ethnic groups, we find 
specific individual comorbidities vary in their association 
with COVID-19 risks: in South Asians, these are diabetes, 
peripheral vascular disease and atrial fibrillation; in the 
Black population, hypertension, atrial fibrillation and 
cardiac failure; in white ethnicity, most comorbidities but 
in particular COPD, chronic kidney disease and RA.
Strengths and weaknesses
Combining Wolverhampton’s health data enabled us to 
evaluate our local population’s heterogeneous demo-
graphic factors and their associations with community 
or hospital NCA and CA and mortality, by uniquely 
approaching these outcomes simultaneously. This local 
nuance complements larger studies, informing appraisal 
of risk from an urban and multiethnic and deprived 
setting, highlighting concerns of extrapolation from 
larger data sets to UK localities. An example of a particular 
strength of the data quality was the cross- check ascertain-
ment of CA, without sole reliance on COVID-19 testing, 
permitting specific categorisation of deaths (COVID-19, 
non- COVID-19 and postdischarge) rather than less accu-
rately into global mortality.
Figure 2 Mortality by ethnicity. Crude mortality by ethnic 
grouping as percentages (A, χ2=184·4, p<0·001), within the 
oldest quintile (B, χ2=92·2, p<0·001) or restricted to those 
with a COVID-19 admission excluding those with a non- 
COVID death (C, χ2=5.92, p=0.115, ns) (other/unknown 
ethnic categories are not shown but were included in the 
analysis).
Table 6 Multinomial regression among those with a 
COVID-19 admission restricted to white, black and South 
Asian ethnic groups (n=797) comparing those who have 




Age 1.05 (1.03 to 1.07), p<0.001
Gender (male) 1.91 (1.3 to 2.83), p<0.01
Smoking current or prior 0.01 (0 to 0.04), p<0.001
Body mass index (kg/m2) 0.92 (0.86 to 0.98), p<0.01
Palliative care registered 7.83 (4.21 to 14.56), p<0.001
Comorbidities ≥3 1.64 (1 to 2.67), p<0.05
Cardiac failure 1.82 (1.14 to 2.92), p<0.05
Chronic kidney disease 1.69 (1.09 to 2.63), p<0.05
Peripheral vascular disease 2.27 (1.12 to 4.59), p<0.05
Results are OR with 95% CIs. Variables not listed from table 1 
were excluded stepwise (backwards) as not significant.
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Limitations of the study
This is a 12- week evaluation spanning the pandemic’s 
upsurge and peak; the population and event number were 
comparatively small; the cause of death in the community 
was unknown, and it is likely that people died away from 
the hospital undiagnosed with COVID-19. A further weak-
ness of the study is that there were some missing data, but 
this was very limited in magnitude and only affected three 
variables: BMI, smoking and ethnicity. We are confident 
that these were dealt with appropriately; for BMI, it is as 
described in Methods; for smoking, we coded all unknown 
smoking as non- smokers on the very likely assumption 
that the vastly greater majority were non- smokers, whereas 
missing ethnicity was coded as ‘unknown’ and analysed 
as such. Given the degree of completeness rather than 
incompleteness of our data, we consider our approach 
approximates to a complete case analysis, arising from 
significant effort on multisource data accrual, integration 
and quality. We thus do not feel that multiple imputation 
should be applied to replace missing data, since we do 
not feel this can possibly improve precision. In so doing, 
we are thus also avoiding the greater and well- recognised 
potential to introduce bias from poorly fitting imputation 
models.27 We consider this to be a strength of the article. 
One further consideration is that while being aligned to 
the population at 99.5% concordance, hospital data were 
not totally drawn from the city population, which varied 
by GP registration, residency or admission from immedi-
ately surrounding areas, and a small proportion of admis-
sions were non- resident or non- registered, so this is not 
strictly an epidemiological study but an observational 
study comparing defined cohorts in tiers of analysis (eg, 
COVID-19 death among CA) where this caveat does not 
apply.28
Implications for clinicians and policymakers
We show that a variety of recognised factors were associ-
ated with COVID-19 death, as with non- COVID-19 death. 
At our local level, CA and death were not strongly associ-
ated with worsening deprivation, with a novel potential 
different relationship in the white population.
Higher absolute and adjusted CA and mortality 
occurred in the black population, whereas they were 
reduced in Wolverhampton’s South Asian community. We 
point out the non- significant association between in- hos-
pital COVID-19 case fatality and ethnicity, raising the 
probability that COVID-19 mortality relates to differential 
risks of exposure, susceptibility and disease contraction 
before hospital admission, let alone the possible avoid-
ance of hospital admission. Two important considerations 
are the potential excessive use of multiple factors and the 
disruption of the perspective from a population’s base 
through hospital admissions to COVID-19- specific admis-
sion, leading to widely varying conclusions and high-
lighting the difficulties of using observational data and 
the potential for collider bias.29 We support the case for 
more localised population- based studies of both hospital 
admission and subsequent death, such as ours, in which 
the denominator and numerator populations can be 
clearly linked and are fully and transparently ascertained 
and characterised. To avoid associations in the data being 
due to the way in which data are sampled, local health 
economies should be mandated to link hospital and 
primary care data across their population level down 
to the unanonymised individual level; they should, in 
preparation for future epidemics, have data quality 
mechanisms in place to ensure accuracy in their demo-
graphics, the accrual of important missing data and the 
triangulation of key outcomes to minimise false- positive 
and false- negative results. This includes the need to have 
a robust, systematic, accurate and timely approach to the 
recording of death whether in the community or hospital 
setting. A defined data set and its capture in routine clin-
ical systems seem apposite.30 Accepting that variation in 
findings in different population subsets is both inevitable 
and valid, we would suggest the need for the public health 
and research community to accommodate uncertainty 
in emergent evidence, learning from the experience of 
previous viral pandemics. This includes the need to have 
a robust, systematic, accurate and timely approach to the 
recording of death whether in the community or hospital 
setting.31
The conveyance of risk
Public health messages are vital to convey, but population- 
adjusted risk rates may confuse, adversely impacting 
behaviours such that, it is feared, hospital admission 
patterns may change unfavourably. Absolute, absolute 
excess, relative, unadjusted and adjusted risk is complex to 
communicate even for healthcare professionals, making 
them susceptible to reasoning errors and misinterpre-
tation of probabilities,32 and individuals, with erstwhile 
health risk, should know about the magnitude of risk in 
a way that can be conceptualised.33 34 For our black popu-
lation, the full modelled OR for COVID-19 mortality was 
2.1, with an absolute risk of 2.2/1000 people or an excess 
risk of 0.9/1000. A black person in Wolverhampton ought 
to be informed that ‘twice as likely to die of COVID-19’ 
compared with the white community can also mean ‘a 1 
in 1000 excess risk’.
Future research
Crucially, we therefore argue that in reporting future 
research of this kind, during the current pandemic and 
beyond, there is an ethical obligation for the standardi-
sation of the conveyance of risk in a manner that spans 
the absolute to the relative so that is easily comprehen-
sible to the individuals and populations at risk and others, 
including health professionals, politicians and the media. 
These are all matters in which the editorial and peer 
review mechanism of our medical journals have a vital 
role.
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